Drug intelligence / Profile preview

N-({(2S)-1-[(3R)-3-amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-yl}methyl)benzamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-{[(2S)-1-[ (3R ) - 3-amino -4-( 2-fluorophenyl ) butanoyl ] pyrrolidin - 2-y l ] methyl } benzamide is a synthetic small molecule belonging to the class of beta amino acid derivatives. It has been studied as an experimental compound and is known to act as an inhibitor of dipeptidyl peptidase IV (DPP-IV, also known as DPP4), a serine protease involved in glucose metabolism and immune regulation. The compound has not been approved for clinical use and remains primarily a research tool or probe for studying DPP-IV function[1][5]. Its molecular formula is C22H26FN3O2, with a molecular weight of approximately 383.46 g/mol[1][5].

Other names
N-{[(2S)-1-[(3R)-3-amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-yl]methyl}benzamideN-{[(2S)-1-[ (3R ) - 3 - amino - 4 -( 2-fluorophenyl ) butanoyl ] pyrrolidin - 2 - yl } methyl } benzamideN-{[(2S)-1-[ (3R ) - 3-amino -4-( 2-fluorophenyl ) butanoyl ] pyrrolidin - 2-y l ] methyl } benzamide
02

Targets

DPP-4 (Dipeptidyl Peptidase-IV)

Beyond the preview

Go deeper on N-({(2S)-1-[(3R)-3-amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-yl}methyl)benzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-({(2S)-1-[(3R)-3-amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-yl}methyl)benzamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call